Method of treating age-related macular degeneration comprising administering a compstatin analog
US9056076B2 · kind B2 · utility
28Cited by
40References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 1, 2012 |
| Grant date | Jun 16, 2015 |
| Priority date | — |
| Expiry date | Mar 20, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention features the use of compstatin and complement inhibiting analogs thereof for treating and/or preventing age related macular degeneration and other conditions involving macular degeneration, choroidal neovascularization, and/or retinal neovascularization. The invention also provides compositions comprising compstatin or a complement inhibiting analog thereof and a second therapeutic agent. The invention also provides compositions comprising compstatin or a complement inhibiting analog thereof and a gel-forming material, e.g., soluble collagen, and methods of administering the compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.